Genthon R, Chassard D, Derobert E, Kabir M, Lendresse P
Laboratoires Hoechst, Paris la Défense, France.
Therapie. 1995 Jan-Feb;50(1):47-51.
Thirty healthy volunteers received piretanide SR 6 mg/day (n = 15) or placebo (n = 15) in a 10-day double-blind parallel-group comparative trial. 24-h urine output was significantly greater with piretanide than with placebo on D1 (1919 +/- 434 ml and 1160 +/- 335 ml respectively, p = 0.001 one-sided) as on D10 (1563 +/- 538 ml and 1236 +/- 435 ml respectively, p = 0.04 one-sided). Nevertheless the evolution of urinary output from D1 to D10 was significantly different (p = 0.008): it remained stable with placebo but diminished with piretanide. The diuretic effect of piretanide was apparent with a supplementary miction between 8 a.m. and 4 p.m. both on D1 and D10. Between 4 p.m. and 8 a.m., the number of mictions was the same in both groups. Thus piretanide SR 6 mg has a mild effect on the number of mictions; it should not alter patients' well-being.
在一项为期10天的双盲平行组对比试验中,30名健康志愿者接受了每日6毫克的缓释吡咯他尼(n = 15)或安慰剂(n = 15)治疗。在第1天,服用吡咯他尼后的24小时尿量显著多于服用安慰剂后的尿量(分别为1919±434毫升和1160±335毫升,单侧p = 0.001),第10天时也是如此(分别为1563±538毫升和1236±435毫升,单侧p = 0.04)。然而,从第1天到第10天尿量的变化有显著差异(p = 0.008):服用安慰剂时尿量保持稳定,而服用吡咯他尼时尿量减少。在第1天和第10天,上午8点至下午4点之间,吡咯他尼的利尿作用明显,排尿次数增加。下午4点至上午8点之间,两组的排尿次数相同。因此,6毫克的缓释吡咯他尼对排尿次数有轻微影响;它不应改变患者的舒适度。